Welcome!

News Feed Item

Modified Citrus Pectin Enhances Anti-Cancer Activity of Two Botanical Formulas, Reduces Metastasis

SAN FRANCISCO, March 26, 2013 /PRNewswire/ -- New research adds to the growing body of evidence that modified citrus pectin (MCP), a natural supplement derived from the pith of citrus fruit, has a powerful effect against cancer. In a study just published in the March 2013 issue of the journal Integrative Cancer Therapies, MCP enhanced the anti-cancer effects of two botanical formulas, one for breast cancer and one for prostate cancer. The combination treatment decreased cancer cell aggressiveness, reduced migration and inhibited metastasis in highly metastatic MDA-MB-231 human breast cancer cells and aggressive, PC-3 hormone refractory human prostate cancer cells. The study was conducted by researchers at the Cancer Research Laboratory at Indiana University Health.

"Metastasis is what makes cancer so deadly," said head investigator Dr. Daniel Sliva, associate professor at the Indiana University School of Medicine. "It's no secret that specific proteins in cancer cells cause aggressive behavior. We now know that by combining modified citrus pectin with these formulas, we can further suppress aggressive cancer activity and significantly reduce metastasis."

The researchers determined that the breast and prostate formulas by themselves decreased cancer aggressiveness, measured by cell adhesion to human fibronectin, a key component in the extracellular matrix, as well as cancer cell migration and invasion. However, when combined with MCP, the anti-cancer effects of both formulas were significantly increased.

The unique anti-breast cancer formula, which contains botanically enhanced medicinal mushrooms, diindolylmethane (an active form of a compound found in cruciferous vegetables) and a variety of botanical extracts, decreased breast cancer cell adhesion by 21 %. However, when co-administered with MCP, researchers observed a 40 % decrease. The anti-cancer effects of this breast formula have been shown in previous published studies to reduce aggressive breast cancer proliferation and metastasis by up to 70 %. This is now the third peer reviewed study showing the safety and efficacy of this anti-breast cancer formula in pre-clinical models.

In addition, the unique anti-prostate cancer formula, which contains a comprehensive blend of antioxidants, herbal extracts, and botanically enhanced medicinal mushrooms, decreased prostate cancer cell adhesion by 9 % in this study. However, when MCP was added, adhesion was reduced by as much as 40 %. Cancer cell migration was also reduced by these combination therapies. This is the fourth peer reviewed published study to demonstrate the anti-cancer effects of this botanical prostate formula in pre-clinical studies.

"This study is very significant because it demonstrates the importance of combining targeted anti-cancer compounds which can work together synergistically for greater impact against the disease," said co-author and integrative medicine expert Isaac Eliaz, MD.  "MCP makes these formulas significantly more effective. Furthermore, the powerful anti-cancer actions demonstrated by these combinations offer a safe and effective adjuvant therapy to patients with aggressive cancers who wish to increase the efficacy of their current treatment regimen."

The researchers also investigated levels of urokinase plasminogen activator (uPA), a protein marker for aggressive cancers. High uPA levels have been found to promote cancer cell adhesion, migration and invasion. Both formulas have been shown in previous research to reduce uPA. Again, combining these formulas with MCP resulted in further suppression of uPA.

Numerous studies have shown that MCP binds and blocks galectin-3, a signaling protein associated with cancer aggressiveness, angiogenesis, aggregation and metastasis. MCP has also been found to significantly increase the immune response including natural killer (NK) cell activation, with demonstrated activity against human leukemia cells. Furthermore, in addition to its synergistic actions with botanical formulas, MCP has been shown to work synergistically with chemotherapeutic agents, such as doxorubicin, allowing for greater efficacy, lower dosages and fewer side effects.

Source: Jiang J, Eliaz I, Sliva D. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells. Integr Cancer Ther. 2013 Mar;12(2):145-52

About Better Health Publishing

Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.

This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com.

SOURCE Better Health Publishing

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Jo Peterson is VP of Cloud Services for Clarify360, a boutique sourcing and benchmarking consultancy focused on transforming technology into business advantage. Clarify360 provides custom, end-to-end solutions from a portfolio of more than 170 suppliers globally. As an engineer, Jo sources net new technology footprints, and is an expert at optimizing and benchmarking existing environments focusing on Cloud Enablement and Optimization. She and her team work with clients on Cloud Discovery, Cloud ...
Everyone wants the rainbow - reduced IT costs, scalability, continuity, flexibility, manageability, and innovation. But in order to get to that collaboration rainbow, you need the cloud! In this presentation, we'll cover three areas: First - the rainbow of benefits from cloud collaboration. There are many different reasons why more and more companies and institutions are moving to the cloud. Benefits include: cost savings (reducing on-prem infrastructure, reducing data center foot print, redu...
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
SYS-CON Events announced today that DatacenterDynamics has been named “Media Sponsor” of SYS-CON's 18th International Cloud Expo, which will take place on June 7–9, 2016, at the Javits Center in New York City, NY. DatacenterDynamics is a brand of DCD Group, a global B2B media and publishing company that develops products to help senior professionals in the world's most ICT dependent organizations make risk-based infrastructure and capacity decisions.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busi...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
"When you think about the data center today, there's constant evolution, The evolution of the data center and the needs of the consumer of technology change, and they change constantly," stated Matt Kalmenson, VP of Sales, Service and Cloud Providers at Veeam Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Today, we have more data to manage than ever. We also have better algorithms that help us access our data faster. Cloud is the driving force behind many of the data warehouse advancements we have enjoyed in recent years. But what are the best practices for storing data in the cloud for machine learning and data science applications?
Andi Mann, Chief Technology Advocate at Splunk, is an accomplished digital business executive with extensive global expertise as a strategist, technologist, innovator, marketer, and communicator. For over 30 years across five continents, he has built success with Fortune 500 corporations, vendors, governments, and as a leading research analyst and consultant.
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science" is responsible for guiding the technology strategy within Hitachi Vantara for IoT and Analytics. Bill brings a balanced business-technology approach that focuses on business outcomes to drive data, analytics and technology decisions that underpin an organization's digital transformation strategy.